Clinical Trial Update: L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet Velocity [Phase 3]

View source ↗

Summary

Phase 3 trial assessing L-Arginine in children with sickle cell disease and increased tricuspid regurgitant jet velocity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: Tanta University | Conditions: Sickle Cell Disease | Phase 3 | Status: COMPLETED